Tuesday, 18 Jun 2019

You are here

Predicting and Preventing Rheumatoid Arthritis

Rheumatologists and physicians are commonly asked, "what can I do to avoid rheumatoid arthritis?"  This is usually a concern for family members of those affected by RA.

However, the answers to this question aren't so clear.  Few patients will inherit RA from a parent or family member. Even monozygotic twins will have less than 20% chance of both developing RA, if one has RA. 

The world's top researchers of the pathogenesis of rheumatoid inflammation (Drs. Klareskog and Holers - along with Dr. Razza) have published a prologue to a series of articles appearing in Rheumatology that will address if we can predict and prevent RA. Specifically, this series will discuss genetic risk factors, the interaction genetic factors and environmental exposures, strategies to predict RA development in at-risk populations, and strategies to prevent RA in those at risk.

They discuss the 5 phases that lead to the development of clinically manifest RA - Genetic/At-Risk,  Environmental exposure, Autoimmune, Early inflammatory, Polyarthritis with established disease. These have led to important investigations in "at-risk" individuals and will soon study if interventions in such people can help to avoid RA onset.

Numerous challenges remain, including: 1) the identification of requisite "triggers", 2) the role of cigarette smoke, toxins, and the microbiota, 3) what is unique and important in those who are seronegative, and 4) are there other disease models we can learn from.

The first article in this series by Karlson et al examines strategies to predict RA onset in at-risk individuals. 

Add new comment

More Like This

EULAR 2019 - Day 1 Report

Here are a few of the highlights from day 1 EULAR in Madrid. 

Low Remission/LDA Rates with TNF inhibitors in Rheumatoid Arthritis


Analysis of Rheumatoid Arthritis patients enrolled and treated as part of the British Society for Rheumatology Biologics Registry shows that sustained remission or low disease activity state (LDA) on TNF inhibitor treatment is uncommon and that combing methotrexate with an anti-TNF increases the odds of sustained remission/LDA.

Proinflammatory Diets May Increase CRP and RA Onset

Despite the lack of good evidence, there has been great speculation about the role of diet in causing or alleviating inflammation. Now there's new research suggesting that proinflammatory diets can increase serum C-reactive protein levels and also the risk of rheumatoid arthritis onset.

Might IL-17 Inhibition Be Effective in RA?

Interleukin 17 (IL-17) inhibitors are highly effective and FDA approved for use in psoriasis, psoriatic arthritis and ankylosing spondylitis. However, many of the initial trials were done in rheumatoid arthritis (RA) where it was projected to be effective, but was not. A recent metanalysis examines how effective IL-17 inhibition was in two RA populations: biologic-naïve or tumor necrosis factor inhibitor inadequate responders (TNF-IR).

Lung Disease in RA: Which Factors are Linked With Mortality?

Among patients with rheumatoid arthritis (RA) who had interstitial lung disease (ILD), the pattern of ILD did influence mortality, but other pulmonary factors also contributed, a meta-analysis suggested.